-
1 Comment
Sapporo Clinical Laboratory Inc is currently in a long term uptrend where the price is trading 5.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.
Sapporo Clinical Laboratory Inc's total revenue rose by 2.5% to $5B since the same quarter in the previous year.
Its net income has increased by 52.0% to $258M since the same quarter in the previous year.
Based on the above factors, Sapporo Clinical Laboratory Inc gets an overall score of 4/5.
Exchange | TSE |
---|---|
CurrencyCode | JPY |
Sector | Healthcare |
ISIN | JP3321100004 |
Industry | Pharmaceutical Retailers |
Market Cap | 3B |
---|---|
PE Ratio | 8.86 |
Dividend Yield | 4.3% |
Beta | 0.3 |
Target Price | None |
Sapporo Clinical Laboratory Inc. operates dispensing pharmacies in Japan. The company offers clinical examination, pathological examination, and holter examination services. It provides food hygiene environmental inspection, including food/processed product, facility hygiene, and food handler inspection services; and radiation management services. In addition, the company develops, sells, and maintains software, such as SCAN clinical testing systems; and offers support services for opening new clinics. Further, it provides HiWeb21 inspection result inquiry services, as well as sells and maintains software relating to clinical testing. The company was incorporated in 1965 and is based in Sapporo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 9776.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025